Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HW6 in Traumatic/Hemorrhagic and Septic Shock
NCT01780129Phase 2Unknown
- Sponsor
- Shenzhen Neptunus
- Start
- Feb 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polydatin in Traumatic shock, hemorrhagic shock, septic shock, sponsored by Shenzhen Neptunus. Status: unknown.
02
Drugs
polydatin
03
Conditions
Traumatic shockhemorrhagic shockseptic shock
Beyond the preview
Go deeper on NCT01780129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01780129.